Clinical Laboratory Testing – T-SPOT.TB Assay Performance

The contract requires the performance of T-SPOT.TB interferon-gamma release assays for tuberculosis screening of Veterans Affairs employees and patients, to be conducted in a laboratory that is CLIA-certified and CAP-accredited with in-house validated protocols. All testing must adhere to strict quality standards to ensure accurate and reliable results for clinical decision-making. The work is under a subcontract arrangement and falls under NAICS code 621511, indicating it pertains to medical and diagnostic laboratories. The solicitation was posted on July 10, 2026, with a response deadline of July 27, 2026, and is managed by the Department of Veterans Affairs through the 256-NETWORK Contract Office 16. The place of performance and specific address details are not specified, but the laboratory must be capable of handling the volume and sensitivity requirements associated with VA patient and staff screening programs. The contract emphasizes compliance with regulatory certifications and internal validation procedures to maintain the integrity of test outcomes.